Attenuation of the BTLA/HVEM Regulatory Network in the Circulation in Primary Sjögren's Syndrome

Annabelle Small, Suzanne Cole, Jing Jing Wang, Sunil Nagpal, Ling-Yang Hao, Mihir Wechalekar

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)
34 Downloads (Pure)


Primary Sjögren’s syndrome (SjS) is an inflammatory autoimmune disorder which targets the lacrimal and salivary glands, resulting in glandular dysfunction. Currently, the immune drivers of SjS remain poorly understood and peripheral biomarkers of disease are lacking. The present study therefore sought to investigate the immune cell constituents of the SjS peripheral blood, and to assess the role of the BTLA/HVEM/CD160 co-stimulatory network by characterizing expression within the periphery. Peripheral blood mononuclear cells (PBMCs) were isolated from whole blood of n = 10 patients with SjS and n = 10 age- and sex-matched healthy control donors. Cells were divided and stained with three panels of antibodies, allowing assessment of T, B, and myeloid cell subsets, and measurement of BTLA, HVEM, and CD160 surface expression by flow cytometry. We identified distinct alterations in proportions of peripheral T, B, and myeloid cell types in SjS compared with healthy controls. Expression of BTLA/CD160/HVEM and frequency of BTLA/CD160/HVEM-expressing cells were significantly altered in peripheral SjS lymphocytes. The proportion of T cells co-expressing BTLA/HVEM and CD160/HVEM were significantly reduced in SjS. We found decreased BTLA and HVEM levels on peripheral B and T cells of SjS patients, and decreased BTLA/HVEM and CD160/HVEM co-expression, demonstrating dysregulation of the BTLA/HVEM axis in the peripheral blood of SjS patients. These results indicate the potential of targeting the BTLA-HVEM axis for the treatment of SjS.
Original languageEnglish
Article number535
Number of pages8
JournalJournal of Clinical Medicine
Issue number3
Publication statusPublished - 1 Feb 2022


  • Sjögren’s syndrome
  • BTLA
  • HVEM
  • co-stimulation


Dive into the research topics of 'Attenuation of the BTLA/HVEM Regulatory Network in the Circulation in Primary Sjögren's Syndrome'. Together they form a unique fingerprint.

Cite this